Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease

Published:2020-02-11 Issue:7 Volume:51 Page:728-736
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Henson Jacqueline B.¹^ORCID,Simon Tracey G.²,Kaplan Alyson¹,Osganian Stephanie²,Masia Ricard³,Corey Kathleen E.²^ORCID

Affiliation:

1. Department of Medicine; Massachusetts General Hospital; Boston MA USA

2. Liver Center; Division of Gastroenterology; Department of Medicine; Massachusetts General Hospital; Boston MA USA

3. Department of Pathology; Massachusetts General Hospital; Boston MA USA

Funder

National Institutes of Health

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15660/fullpdf

Reference32 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

4. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States;Kim;Hepatology,2013

5. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis;Targher;J Hepatol,2016

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up;Hepatology Research;2024-08-19

2. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26

3. Risk of Adverse Events in Anticoagulated Patients With Atrial Fibrillation and Nonalcoholic Fatty Liver Disease;The Journal of Clinical Endocrinology & Metabolism;2024-06-12

4. Control of cardiometabolic risk factors and their association with carotid intima media thickness among patients with type 2 diabetes mellitus-single center experience in a developing country;Turkish Journal of Medical Sciences;2024-06-12

5. Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment;International Journal of General Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3